(Reuters) – Europe became the second region after Latin America to surpass 250,000 deaths on Saturday, according to a Reuters tally, with record numbers of daily COVID-19 infections reported in the past two weeks.
Moderna Inc. completed the enrollment of 30,000 participants in a late-stage study testing the company’s experimental coronavirus vaccine, with over a third of the participants from communities of color.
Global coronavirus cases rose by more than 400,000 for the first time, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak.
The global coronavirus death toll surpassed 1 million according to a Reuters tally, a bleak statistic in a pandemic that has devastated the global economy, overloaded health systems and turned daily life upside down.
Global coronavirus cases surged past 25 million, according to a Reuters tally, as India marked a worldwide record for daily new cases in the Covid-19 pandemic.
Mexico aims to conduct late-stage clinical trials for Covid-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said.
Global coronavirus cases pushed past 20 million, according to a Reuters tally, with the United States, Brazil and India accounting for more than half of all known infections.
The United States Food and Drug Administration approved Bayer’s Lampit (nifurtimox) for use in pediatric patients for the treatment of Chagas disease caused by Trypanosoma cruzi.
Global coronavirus cases exceeded 10 million on Sunday according to a Reuters tally, marking a major milestone in the spread of the respiratory disease that has so far killed almost half a million people in seven months.
Global coronavirus cases surpassed 6 million, according to a Reuters tally, as Latin America reported a grim milestone of 50,000 deaths from the disease.
